Month: November 2019

[Editor’s note: “6 Monthly Dividend Stocks to Buy” was previously published in Sept. 2019. It has since been updated to include the most relevant information available.] Most dividend stocks pay their shareholders quarterly, but a few dividend-yielding stocks offer monthly distributions. The group is small: less than 100, with many of the offerings being exchange-traded funds
0 Comments
Back in July, I wrote that Aurora Cannabis (NYSE: ACB) had a cash burn problem. In the past week, it has become painfully clear HEXO (NYSE: HEXO) stock has one too. Source: Shutterstock The HEXO stock price has tanked another 22.8% in the past two weeks. Unfortunately, analysts are not recommending investors buy the dip
0 Comments
Earlier this week, an H.C. Wainwright analyst initiated coverage of GW Pharmaceuticals (GWPH), adding to the buzz already surrounding this increasingly popular cannabis stock. On Wednesday, H.C. Wainwright analyst Douglas Tsao initiated coverage, giving the stock a “Buy” rating and $170 price target. In a note to investors, Tsao said that he expects GWPH stock
0 Comments
Hey everybody Dave Bartosiak with Trending Stocks at Zacks.com. Apparently you folks are a little too swept up in the holiday spirit. I like a good Christmas story as much as anybody out there but the Miracle on Pennsylvania Avenue hasn’t even filmed a trailer yet. King Donald hasn’t had his official coronation and everyone
0 Comments
People pass a sign for JPMorgan Chase at it’s headquarters in Manhattan, New York City. Spencer Platt | Getty Images Federal prosecutors have asked for two civil cases against J.P. Morgan Chase be put on hold until they have finished a related criminal prosecution involving current and former precious metals traders at the nation’s largest
0 Comments
Inventory injections will start declining over the coming weeks The market was expecting an injection of 86 bcf The price action after the EIA data continues to be bullish After the most recent release of inventory data from the Energy Information Administration, there are only two weeks left in the 2019 injection season in the
0 Comments
On Oct. 23, Microsoft (NASDAQ:MSFT), released its fiscal  first-quarter results.  They showed improvement by its cloud segment, Azure, in particular and by its entire business in general. Source: Peteri / Shutterstock.com In 2019, MSFT stock is up about 40%. I believe that the strong performance of Microsoft stock has been based on robust fundamentals, which I
0 Comments